Accretion Pharmaceuticals (NSE:ACCPL) Buyback Yield %: -17.05 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ACCPL Accretion Pharmaceuticals Ltd NSE:ACCPL
18 GF Score
Price ₹155.50
! 6 Warning Signs
View Full Analysis

What is Accretion Pharmaceuticals Buyback Yield %?

Accretion Pharmaceuticals NSE:ACCPL -0.96% 18 Buyback Yield % is -17.05 as of Jul. 14, 2026. GuruFocus rates NSE:ACCPL with a GF Score™ of 18/100. The stock has 6 warning signs investors should review. Among 290 Drug Manufacturers companies, Accretion Pharmaceuticals ranks worse than 85.86% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Accretion Pharmaceuticals's current buyback yield was -17.05%.

Accretion Pharmaceuticals Buyback Yield % Related Terms

Accretion Pharmaceuticals Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Accretion Pharmaceuticals's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accretion Pharmaceuticals Buyback Yield % Chart

Accretion Pharmaceuticals Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Buyback Yield %
0.00 0.00 0.00 0.00 -43.73

Accretion Pharmaceuticals Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Buyback Yield % Get a 7-Day Free Trial 0.00 0.00 0.00 -40.47 -42.10

NSE:ACCPL vs LLY, JNJ, ABBV: Buyback Yield % Comparison

For the Drug Manufacturers - General subindustry, Accretion Pharmaceuticals's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accretion Pharmaceuticals Buyback Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Accretion Pharmaceuticals's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Accretion Pharmaceuticals's Buyback Yield % falls into.


NSE:ACCPL
18GF Score
Accretion Pharmaceuticals Ltd NSE:ACCPL
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accretion Pharmaceuticals Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Accretion Pharmaceuticals's Buyback Yield for the fiscal year that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 297.546) / 680.3663
=-43.73%

Accretion Pharmaceuticals's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 297.546) / 706.73955
=-42.10%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -17.05 mean?
Accretion Pharmaceuticals (NSE:ACCPL) has a Buyback Yield % of -17.05 as of Jul. 14, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Accretion Pharmaceuticals and its competitors. According to the industry distribution chart, Accretion Pharmaceuticals ranks #249 out of 290 companies in the Drug Manufacturers industry, placing it in the top 85.9%.
Is Accretion Pharmaceuticals' Buyback Yield % too high?
Accretion Pharmaceuticals' current Buyback Yield % is -17.05. Based on the distribution chart, Accretion Pharmaceuticals ranks #249 out of 290 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Accretion Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Accretion Pharmaceuticals' Buyback Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Accretion Pharmaceuticals ranks #249 out of 290 companies for Buyback Yield %. This places Accretion Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Drug Manufacturers company?
A good Buyback Yield % depends on the Drug Manufacturers industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Accretion Pharmaceuticals and its competitors. Accretion Pharmaceuticals's current Buyback Yield % is -17.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accretion Pharmaceuticals stock overvalued right now?
Accretion Pharmaceuticals (NSE:ACCPL) has a current Buyback Yield % of -17.05. The current Buyback Yield % is -17.05. Accretion Pharmaceuticals' overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Accretion Pharmaceuticals (NSE:ACCPL), the current Buyback Yield % is -17.05 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Accretion Pharmaceuticals Business Description

Address 29, Xcelon Industrial Park-1, Behind Intas Pharmaceuticals, Vasna-Chacharwadi, Ta - Sanand District, Ahmedabad, GJ, IND, 382213
Accretion Pharmaceuticals Ltd is engaged in the manufacturing of Medicinal & Pharmaceutical Products. The company manufactures tablets, oral liquid, capsule, cream, ointment, mouthwash, dusting powder, gel, ear drops, lotion, shampoo, powder, syrup, among others.
18GF Score

Get the complete analysis for NSE:ACCPL

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹155.50
Price